"PRELIMINARY PROGRAMME International Conference on Clinical PET and"
PRELIMINARY PROGRAMME International Conference on Clinical PET and Molecular Nuclear Medicine (IPET-2007), Bangkok, Thailand, 10-14 November 2007 International Organizing Committee: H. Amaral, Chile P. Andreo, IAEA T. Bokulić, Croatia M. Dondi, IAEA H.H. Coenen, Germany M. Haji-Saeid, IAEA F. Roesch,,Germany R. Kamel, IAEA M. Schwaiger, Germany N. Ramamoorthy, IAEA E. Bombardieri, Italy E. Saalminen, IAEA A. Soricelli, Italy K.K. Solanki, IAEA N. Tamaki, Japan C. Locharernkul, Thailand C. Anderson, USA P. Conti, USA IAEA Secretariat: Scientific Secretaries: M. Dondi M. Haji-Saeid K. Solanki Symposium Coordinators: H.Schmid R. Perricos Administrative Support: D. Umgeher Location of the Conference: Convention Center, Chulabhorn Research Institute 54 Moo 4 Vibhavadee-Rangsit Highway Bangkok 10210, Thailand Tel: (66)29848820-34/ Fax: (66)29848665 Working Language: English Resolutions: No resolutions may be submitted for consideration on any subject; no votes will be taken. As of July 2007 OVERVIEW Saturday, 10 November 2007 14:00–16:30 Registration 16:30–18:30 Opening Session 18:30–19:00 Cultural Programme 19:00–21:00 Reception Sunday, 11 November 2007 08:00–09:00 CME – Basic PET 09:00–10:30 PET Oncology I 10:30–11:00 Coffee/Tea Break 11:00–12:30 PET Oncology II 12:30–14:00 Lunch Break 14:00–15:30 Presentations and Panel Discussion: Challenges in Setting-up a PET Programme 15:30–16:00 Coffee/Tea Break 16:00–17:30 PET Oncology III Monday, 12 November 2007 08:00–09:00 CME – Radiopharmacy 09:00–10:30 Radiopharmacy 10:30–11:00 Coffee/Tea Break 11:00–12:30 Practical Aspects of Multimodality Imaging 12:30–14:00 Lunch Break 14:00–15:30 Interactive Parallel Poster Sessions 15:30–16:00 Coffee/Tea Break 16:00–17:40 Physics Quality Control and Protocol Standardization Tuesday, 13 November 2007 08:00–09:00 CME – Image Interpretation Neurology & Cardiology 09:00–10:30 PET Neurology 10:30–11:00 Coffee/Tea Break 11:00–12:30 PET Cardiology 12:30–14:00 Lunch Break 14:00–15:30 SPECT in the PET era 15:30–16:00 Coffee/Tea Break 16:00–17:30 Presentations and Panel Discussion: Training & Education Wednesday, 14 November 2007 08:00–09:00 CME – Therapy Assessment and Planning 09:00–10:30 PET: Therapy Prediction/Assessment 10:30–11:00 Coffee/Tea Break 11:00–12:30 Closing Session: Highlights Lecture Future Directions Closing Remarks 1 PROGRAMME SATURDAY, 10 NOVEMBER 2007 14:00–16:30 Registration and distribution of conference material - 16:30--18:30 Opening Session Chair: M. Dondi, IAEA Co-Chair: TBC Welcome Remarks: Host Government Representative Opening of the Conference: On behalf of the IAEA Professional Societies: P. Conti, Society of Nuclear Medicine (SNM) A. Cuocolo, European Association of Nuclear Medicine (EANM) A. Ellmann, World Federation of Nuclear Medicine & Biology (WFNMB) J. Czernin, Academy of Molecular Imaging (AMI) Her Royal Highness Princess Chulabhorn Mahidol President of the Chulabhorn Research Insitute No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 001 Y. Sasaki Japan Overview on impact of PET at general public level (invited) (18:10) 18:30–19:00 Cultural Programme 19:00–21:00 Reception *TBC: To Be Confirmed 2 SUNDAY, 11 NOVEMBER 2007 08:00–09:00 CME – Basic PET Chair: (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 001CME P. Conti USA How FDG work? - Basic Skills in Image Interpretation (invited) (08:00) 002CME H.A. Macapinlac USA Image Interpretation Oncology (invited) (08:30) 09:00–10:30 PET Oncology I Chair: E. Bombardieri, Italy Co-Chair: A. Ellmann, South Africa (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 002 P. Conti USA Oncology Lung Cancer (invited) (09:00) 003 S. Stroobants Belgium Oncology Lymphoma (invited) (09:20) 004 H.A. Macapinlac USA Oncology Melanoma (invited) (09:40) 005 R. Kumar India PET-CT for Evaluation of Chemotherapy Response in Patients (10:00) M. Chawla with High-grade Lymphomas M. Nadig D. Halanaik C. Bal, et al. 006 F. Redondo Chile Evaluation of Pulmonary Tumors with 18F-FDG PET/CT (10:15) C. Suarez R. Pruzzo H. Amaral 10:30–11:00 Coffee/Tea Break 3 SUNDAY, 11 NOVEMBER 2007 (cont’d) 11:00–12:30 PET Oncology II Chair: S. Stroobants, Belgium Co-Chair: TBC No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 007 T. Hany Switzerland PET/CT in Colorectal and Gastro-Intestinal Tumors (invited) (11:00) 008 J.-K. Chung Korea, FDG PET in Head & Neck and Thyroid Cancers (invited) (11:20) Republic of 009 E. Bombardieri Italy Breast Cancer (invited) (11:40) 18 010 G. Wang China The Clinical Significance of F-FDG PET/CT on Patients with (12:00) E.W.F. Lau Australia Nasopharyngeal Carcinoma R. Shakher R.E. Ware E. Hong, et al. 011 S. Pathak India Impact of Whole Body PET CT in Staging Patients of Carcinoma (12:15) V. Rangarajan Esophagus N.C. Purandare S. Shah N. Singh, et al. 12:30–14:00 Lunch Break 4 SUNDAY, 11 NOVEMBER 2007 (cont’d) 14:00–15:30 Presentations and Panel Discussion: Challenges in Setting-up a PET Programme: Developing Countries – Experience Chair: M. Dondi, IAEA Co-Chairs: M. Haji-Saeid, R. Kamel, IAEA No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization M. Dondi IAEA Introductory Comments / PET around the World 012 C. Locharernkul Thailand Challenges in Setting-up a PET Programme: Thailand (14:05) Experience (invited) 013 M.A. Abdul Khader Malaysia Challenges in Setting-up a PET Programme: Experience from (14:15) Malaysia (invited) 014 H. Amaral Chile Challenges and Setting up a PET Programme in Chile (invited) (14:25) 015 A. Ellmann South Africa Challenges in Setting-up a PET Programme – South African (14:35) M.M. Sathekge experience (invited) 016 TBD* Economics of PET service (invited) (14:45) (15:05) Discussions 15:30–16:00 Coffee/Tea Break *TBD: To Be Decided 5 SUNDAY, 11 NOVEMBER 2007 (cont’d) 16:00–17:30 PET Oncology III Chair: P. Conti, USA (TBC) Co-Chair: TBD No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 017 J. Gelovani USA Emerging Clinical PET Tracers for Oncology (FLT, Choline, (16:00) Acetate) (invited) 018 J. Czernin USA Molecular Imaging in Quality Health Care (invited) (16:20) 019 R. Baum Germany Receptor PET/CT with Ga-68 labeled somatostatin analogues (16:40) for the diagnosis, staging and restaging of patients with neuroendocrine tumors undergoing peptide receptor radionuclide therapy – current status and future perspectives (invited) 020 B. Malkowski Poland The Value of the PET/CT FDG in the Diagnostics of Ovarian (17:00) T. Pietrzak Cancers in Patients with Increased Level of Ca 125 Marker A. Nowakowska A. Kachniarz M. Grabiec 021 N.Ö. Küçük Turkey PET/CT Imaging in Multiple Myeloma; Ankara University (17:15) M. Kizil Experience - Preliminary Results E. Özkan E. Soykan G. Aras, et al. 6 MONDAY, 12 NOVEMBER 2007 08:00–09:00 CME – Radiopharmacy Chair: K.K. Solanki No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 003CME S. Schwarz USA Comparison of National PET Radiopharmaceutical Regulations (08:00) (invited) 004CME Y. Fujibayashi Japan Quality Assurance/Quality Control of PET Radiopharmaceuticals (08:30) (invited) 09:00–10:30 Radiopharmacy Chair: K.K. Solanki, IAEA Co-Chair: Y. Fujibayashi, Japan No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 022 C.J. Anderson USA A New Generation of Radiometal-based Radiopharmaceuticals (09:00) for PET Oncological Imaging (invited) 023 H.H. Coenen Germany Chemistry of Potent Tracers for PET Studies of Neuronal (09:20) Functions (invited) 68 024 F. Rösch Germany The Ge/Ga Radionuclide Generator: Processing and Potential (09:40) for Radiopharmaceutical Chemistry and Nuclear Medicine (invited) 18 025 S.K. Nandy India Synthesis of [ F]-Fluoromisonidazole using a General Purpose (10:00) M.G.R. Rajan Fluorination Module and Combination Purification Column A. Korde P.S. Soni 026 G.-J. Beyer Germany The Potential of PET Cyclotron Installations for the Production of (10:15) J.J. Cŏmor Serbia uncommon Positron Emitting Isotopes 10:30–11:00 Coffee/Tea Break 7 MONDAY, 12 NOVEMBER 2007 (cont’d) 11:00–12:30 Practical Aspects of Multimodality Imaging Chair: A. Bischof Delaloye, Switzerland (TBC) Co-Chair: T. Chaiwatanarat, Thailand No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 027 D. Townsend USA PET/CT - Current Status (invited) (11:00) 028 G. El Fakhri USA Development in SPECT Technologies (invited) (11:20) 029 O. Israel Israel Update of SPECT/CT in Clinics (invited) (11:40) 030 M.A. Guirao Argentina Combined PET-CT and PET-MRI Imaging from Non hybrid (12:00) M. Namias Cameras: Protocol Approaches and Clinical Experience C. Llina R. Isoardi 031 S. Shah India Justification of a Whole Body PET CT Study in Post-treatment (12:15) V. Rangarajan Assessment of Nasopharyngeal Carcinoma N.C. Purandare S. Pathak N. Singh 12:30–14:00 Lunch Break 8 MONDAY, 12 NOVEMBER 2007 (cont’d) 14:00–15:30 Interactive Parallel Poster Sessions SESSION I – Clinical PET Chair: H.A. Macapinlac, USA No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 18 100p F. Redondo Chile F-FDG PET/CT in the Evaluation of Transitional Cell R. van Cauwelaert Carcinoma of the Upper Urinary Tract R. Pruzzo H. Amaral 18 101p R. Pruzzo Chile F-FDG PET/CT in the Evaluation of Gallbladder Carcinoma - H. De La Fuente Initial Experience E. Waugh F. Redondo H. Amaral, et al. 102p M.J. Jofré Chile Usefulness of FDG - PET in the Evaluation of Patients with L.T. Massardo Colon and Rectal Cancer in a PET Center in Chile J. Canessa P. Sierralta P. González 18 103p L.T. Massardo Chile Gastrointestinal Stromal Tumors (GIST) Assessment using F- M.J. Jofré Fluor-Deoxyglucose J. Canessa M.P. Sierralta P. González, et al. 18 104p S. Gao China The Value of F-FDG PET Imaging in the Differential Diagnosis Z-G. Li of Parkinsonian Disorders Using Statistical Parametric Mapping D-C. Li Method Y-S. Li 107p Z. Zhu China Experiences on Improving Diagnostic Accuracy of FDG PET by F. Li Characterizing, Reducing, and Avoiding the High-Level W. Cheng Physiological Uptakes at Abdomen and Pelvic Region X. Cheng 11 18 108p C. Zuo China The Combined Use of C-Choline and F-FDG PET in the Y. Guan Diagnosis of Brain Tumor Z. Huang J. Zhao 9 No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 109p D. Dodig Croatia The Value of F-18-FDG triple-head coincidence PET in the D. Huić Post- treatment Evaluation of Patients with Lymphoma A. Mutvar I. Radman D. Grošev, et al. 110p J.P. Oliva González Cuba Dual Tracer/Dual Isotope Ga-68 DOTA-NOC and F-18 FDG R.P. Baum Germany PET/CT - A one Day Protocol in a Child with Neuroblastoma for Determining the Rector Status and the Metabolic Tumor State 111p P. Koranda Czech Republic 18F-FDG PET/CT in Patients with Neuroendocrine Tumors M. Mysliveček E. Buriánková R. Formánek 112p K. Taalab Egypt Experience and Role of FDG-PET Lymphoma Imaging in Egypt H. Farag 114p A. Agrawal India Does FDG-PET help in Preoperative Management of a Thyroid N. Nair Nodule? U.N. Nayak 115p A. Agrawal India Can Brown Fat Uptake of 18F-FDG be Reduced by Beta- N. Nair Blockers? 116p S. Shah India Yield of PET CT in Evaluating Cases of Medullary Carcinoma V. Rangarajan Thyroid with Elevated Calcitonin Levels N.C. Purandare N. Singh S. Pathak 117p S. Singh India Impact of FDG PET/CT in Management of Patients with V. Rangarajan recurrent Breast Cancer - Initial Experience N.C. Purandare S. Shah S. Pathak, et al. 118p B. Malkowski Poland The Comparison of the CT and PET/CT FDG in the Diagnostics K. Pluzanska of Testicular Cancer T. Pietrzak A. Petrus J. Siekiera 119p B. Malkowski Poland The Comparison of the CT and PET/CT FDG in the Diagnostics W. Zegarski of Colon Cancer in Patients with an increased level of CEA J. Dzierzawski Marker K. Kula J. Jaroszek, et al. 10 Designating Member Name Title State/Organization 120p B. Malkowski Poland Initial Polish Experience in the Diagnostic Utility of 18-FDG PET B. Jurczyszyn in the Assessment of Patients with Multiple Myeloma T. Pietrzak A.B. Skotnicki 121p L.A. Bokeria Russian Federation FDG-PET for Assessment of Therapy in Lymphoma Patients I.P. Aslanidis O.V. Mukhortova I.V. Shurupova, I.V. Ikaeva, et al. 122p B.M. Magsombol Singapore Role of FDG-18 PET/CT in the Diagnosis of Unknown Primary A.K. Padhy Cancer U. Pua A.S.W. Goh 123p C. Chotipanich Thailand Unexplained Rising Carcinoembryonic Antigen (CEA) and the C. Sritara Utility of F18-FDG PET-CT in Recurrent Colorectal Cancer: S. Chiewvit Preliminiary Experiences in Thailand P. Sirimas S. Phongkitkarun, et al. 124p K. Kingpetch Thailand 18F-FDG Scan in Well-Differentiated Thyroid Cancer Patients S. Sirisalipoch with Increased Thyroglobulin Antibody but Negative I-131 Total S. Tepmongkol Body Scan T. Chaiwatanarat 125p F. Dede Turkey Bilateral Pheochromocytomas and Neuroendocrine Tumor of T. Ones Pancreas Demonstrated with FDG-PET/CT in a Patient with von T.Y. Erdil Hippel-Lindau Syndrome: A Case Report H.T. Turoglu B. Unalan 194p H. Moustafa Egypt The Role of FDG-PET Imaging in Lymphoma. Egyptian K. Taalab Experience in 460 Cases. A. Saleh 11 SESSION II – Clinical SPECT Chair: TBD No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 126p V.E. Soroa Argentina SPECT in PET era: Do Gamma Cameras still have a Role in M.H. Velazquez the Oncological Diagnosis and Management? Espeche C.A. Giannone 127p S.B. Sergieva Bulgaria Role of Planar and SPECT 99mTc-MIBI Scintigraphy in K.V. Timcheva Breast Cancer Patients before and after Neoadjuvant N.D. Hadjiolov Chemotherapy 128p J. Tang China The Primary Clinical Application Study of Technetium-99m Z. Liu Labeled Ethylenedicysteine-Decocyglucose in Tumor Y. Yang Glucose Metabolic Imaging 129p N. Delgado Colombia Preliminary Results of the Evaluation of 99mTc- M. Martinez EDDA/HYNIC-Tyr3-Octeotride Prepared from Lyophilized A. De Los Reyes Kits Vs 111 In-DTPA-Octeotride with SPECT Images in A. Llamas Patients with Metastatic Neuroendocrine Tumors in the National Cancer Institute of Bogota-Colombia 130p O. Grisales Colombia Carcinoid Tumours, Diagnosis and Staging Using 111-In J. Ahumada DTPA Octreotide. Preliminary Experience. L. Cadavid A.M. Romero 131p L.S. Veloza Colombia Internal Dosimetry of Iodine 131 Using SPECT Images in M.C. Mejia Patients with Thyroid Carcinoma in the Instituto Nacional de Cancerologia, Bogota, Colombia 132p A. Dimitrakopoulou- Germany Use of Ga-68-Labeled Peptides and PET for Diagnosis and Strauss Therapy Monitoring in Oncological Patients P. Hohenberger S. Koukouraki Greece V. Georgoulias M. Eisenhut, et al. Germany 135p S. Padma India Incremental Value of Technetium MIBI SPECT, MR Fusion P. Shanmuga Imaging in Evaluation of Intracranial Space occupying Sundaram Lesions S. Kumar P. Kumar 136p M. Parmar India Tc99m DMSA-V Scintigraphy in Post-operative Follow-up of H.V. Sunil Patients with Medullary Thyroid Carcinoma A. Bhattacharya B. Singh B.R. Mittal 12 No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 137p R.A. Cano Peru Usefulness of SPECT in Sentinel Node Localisation R.E. Morales A. García G. Salvatierra J. Márquez, et al. 138p E. Dziuk Poland 99m-Tc-HYNIC-TATE Receptor Imaging and Computed N. Szalus Tomography (CT) in Neuroendocrine Tumour Imaging G. Kaminski J. Pietrzykowski 139p A. Kazmierczak Poland Myocardial Perfusion gated SPECT in Women with Exercise E. Dziuk Stress Test 140p E. Dziuk Poland Assessment of Cardiovascular System in Subclinical G. Kaminski Hyperthyroidosis M. Dziuk 141p C. Buzumurga Romania The Diagnosis of CAD in Patients with High Blood Pressure C. Suciu - The Role of Myocardial Perfusion Imaging SPECT with R. Capalneanu 99m-Tc Tetrofosmin 142p M. Gherghe Romania Myocardial Perfusion Imaging - A Possible Role in G. Aron Revealing Endothelial Dysfunction in Patients with Angina E. Radu and Normal Coronary Angiogram O. Zara 143p A. Rimbu Romania Value of 99m Tc-MIBI Brain SPECT in Differentiating G. Marinescu Recurrence and Radiotherapy Effects in Tumors Brain S.T. Ghita Patients C. Mazilu P. Murgoci, et al. 144p V. Artiko Serbia SPECT Radioimmunodetection of Colorectal Carcinomas V. Obradović using 111-In Labelled Monoclonal Antibodies M. Petrović N. Petrović D. Šobić-Šaranović, et al. 145p V. Obradović Serbia Detection of Neuroendocrine Tumors using SPECT 99mTc- V. Artiko Tektrotyd N. Petrović B. Popović D. Macut, et al. 146p A. Dustov Tajikistan Molecular Nuclear Medicine in the Management of Thyroid A. Karimov Cancer 13 SESSION III – Radiopharmacy Chair: S. Schwarz (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 148p M. Nader Austria Multi-Tracer Syntheses at a Radiopharmaceutical Production Centre "A Shift of Paradigm" 149p D. Bemelmans Brazil Transport of Radioactive Materials of Short Half-Life A.C.F. Sobreira 150p R. Santos Oliveira Brazil Implication of Amendment 49 in Brazilian Radiopharmacy S.W. Smith USA A.M.A. Carneiro Leão Brazil 151p L. Rojo Chile 18F-Lansoprazole: Chemical and Biological Studies M. Avila Towards the Development of a New PET Radiotracer M. Chandia R. Becerra R.B. Maccioni 152p Y. Li China Automatic Synthesis of [11C]Raclopride and Initial Clinical W. Yan Application on Parkinson's Disease L. Cai S. Gao 153p G.P. India Radiolabelled Oligosaccaride Probes: An Approach for Bandopadhyaya Infection Imaging J. Shukla R. Kumar C.S. Bal 154p S. Lata India Radiolabelling of 68Gallium DOTATOC: Initial Experience N. Naswa C.S. Bal A. Malhotra 155p S.K. Nandy India Preliminary Studies on a Rapid Radiosynthesis Procedure M.G.R. Rajan for [F-18]-FHBG Using a Non-HPLC Purification Technique A. Korde P.S. Soni 156p M.G.R. Rajan India Multi-Purpose Synthesis Module for Preparing [F-18]- S.K. Nandy Labelled Compounds P.S. Soni 157p M. Gandomkar Iran, Synthesis and in vitro/in vivo Evaluation of [99mTc-EDDA- R. Najafi Islamic Republic of HYNIC]-NATE as a New Radiopharmaceutical for M. Shafiei Somatostatin Receptor Scintigraphy 14 No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 158p M. Sadeghi Iran, Cyclotron Production of No-Carrier-Added 64CU for Cancer Islamic Republic of Radiotherapy Agent and Positron Emission Tomography M. Avila Chile (PET) C. Tenreiro 159p M. Salouti Iran, Estimating Tumor/Non-Tumor Uptake from Radiolabeled H. Rajabi Islamic Republic of Monoclonal Antibodies, based on Scintigraphic Imaging to M.H. Babaei avoid Killing the Animal Models M.J. Rasaee| M. Shafiee, et al. 161p J.S. Chai Korea, Republic of Progress Report of Development of KIRAMS-30 Cyclotron D.H. An for RI Productions in Korea I.S. Jung J.S. Kang T.K. Yang, et al. 162p E. Janevik- Macedonia, The The Role of Iodine-131 MIBG and Technetium-99m Ivanovska Frmr.Yug.Rep. of DMSA(V) in Evaluation of Malignant Disease M. Angeleska M. Stojmirov B. Andonovski S. Miceva Ristevska 164p M.M. Saw Singapore Second Generation 99mTc-Radiopharmaceuticals for Molecular Imaging Era 165p S. Somanesan Singapore Disruption to daily PET Radiopharmaceutical Production arising from Cyclotron & Synthesis Module Problems, Corrective Actions taken and Associated Downtime 166p F. Macášek Slovakia The Costs and Benefits of the Quality Management and Best Practice of [18F]FDG Manufacturing 167p O. Alonso Uruguay Is Tc-99m Glucarate a Tracer of Tumor Necrosis? J.P. Gambini Comparison with F-18 FDG PET in a Breast Cancer Model X. Zhang USA and Preliminary Clinical Evaluation P. Cabral Uruguay S. Figueroa, et al. USA 168p J. Chang USA Quality Assurance on F18 Production: Experience with GE II J. Mullis Target/Ion Source System for the MiniTracer Cyclotron M. Hyatt R. McKay J. Wells, et al. 15 No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 169p W. He USA Measurement of Muscle and Whole Body Glucose Y.-M. Yu Metabolism in vivo by Combined Stable Isotope and Positron D. Bischoff Emission Tomography Techniques - Validation in an Animal E. Carter Model R.G. Tompkins, et al. 170p W. He USA In vivo Measurements of Whole Body (WB) and Skeletal Y.-M. Yu Muscle Glucose Metabolism under Basal and Euglycemic D. Dlahi Insulin Clamp by Combined Positron Emission Tomography R.G. Tompkins and Stable Isotope (SI) Tracer Studies A.J. Fischman 171p S.K. Sharma USA Basic Requirements of Quality Control of PET G. Krause Radiopharmaceuticals M. Ebadi SESSION IV – Physics, Radiation Protection Chair: D. Townsend, USA No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 172p L.C. Arribas Argentina Image Fusion Based on Images of SPECT and CT Modalities S.L. Mosconi Acquired in Separated Scanners F. Cismondi C. Padín F. Da Ros, et al. 173p C. Llina Argentina PET-TAC Protocol Acquisition for Whole Body Corregistration S. Mosconi 174p L.G. Strauss Germany Fusion of PET and Molecular Biology: Combined Assessment of S. Klippel Quantitative Dynamic PET Data and Gene Array Results Using D. Koczan the GenePET software L. Pan C. Cheng, et al. 175p L.G. Strauss Germany Quantitative, Dynamic PET for the Detection and Differentiation D. Koczan of Bone Lesions L. Pan C. Cheng U. Haberkorn, et al. 176p S. Pellet Hungary Hungarian Experiences with PET/CT Applications from a L. Ballay Radiation Protection Point of View 178p I. Bahnarel Moldova, Quality Control and Quality Assurance in Radiation Medicine in L. Coretchi Republic of the Republic of Moldova 16 No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization N. Dimov 180p P. Celik Turkey Software Module Development for High Resolution PET U. Pietrzyk Germany Systems G. Capa Kaya Turkey M. Khodaverdi Germany SESSION V – Emerging PET Programmes Chair: H. Amaral, Chile (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 181p M. Namías Argentina Experience of Setting in Operation a PET/CT-Cyclotron Facility in J. Passadore Argentina G. Scarpignato A. Durán E. Obenaus, et al. 182p L. Nisa Bangladesh Prospect of PET-CT in a Developing and Transition Economy like Bangladesh 18 183p M. Figols de Brazil Brazilian Experience in the Production of F-FDG Barboza N.T.O. Fukumori R. Herrerias L.C. Sumiya W. Bruzinga, et al. 184p P.S. Soni India Maintenance & Operational Aspects of Medical Cyclotron Facility M.G.R. Rajan - Indian Experience B.K. Sharma A.K. Kohli 185p E. Janevik- Macedonia, Feasibility Study for PET - The Right Choice for Establishing PET Ivanovska The Former Republic of in Emerging Countries S. Miceva Ristevska V. Lazarevik A. Arnikov S. Petrov 186p A. Qureshy Pakistan Establishing the First PET & Cyclotron Facility in Pakistan - Experiences of a Third World Country 188p G.G. Shimchuk Russian Federation Development of Russian's Industrial and Technological V.A. Kiselev Resources required to produce PET Center Equipment A.V. Sidorov O.A. Shutukovsky E.P. Derevjanko 189p F. Mut Uruguay Positron Emission Tomography and Related Technology in Latin- America: Current Situation, Prospects , and Needs 17 SESSION VI – Training & Education Chair: A. Ellmann, South Africa (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 190p R. Jaimovich Chile Quality Control and Learning Experience in Clinical Nuclear L.T. Massardo Cardiology at a Teaching Hospital Facility P. González I. Alliende 191p S. Nazarenko Estonia Training Management at Establishing a PET/CT Service in a K. Goldstein Country with Limited Economic Resources 192p T.N.B. Pascual Philippines Cooperative Learning in the Modern Era of PET Education and J.F.Y. Santiago Training: The Philippine Experience 193p M.M. Saw Singapore Designing a University-Level Module on Molecular Imaging Chemistry 15:30–16:00 Coffee/Tea Break 18 MONDAY, 12 NOVEMBER 2007 (cont’d) 16:00–17:40 Physics Quality Control and Protocol Standardization Chair: D. Townsend, USA Co-Chair: G. El Fakhri, USA No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 032 A.A. Lammertsma Netherlands Protocol Standardization (EORTC) (invited) (16:00) 033 G. El Fakhri USA PET Instrumentation QA/QC (invited) (16:20) 034 D. Schlyer USA Simultaneous PET/MRI in Breast Cancer: Development of the (16:40) P. Vaska Technology C. Woody S.R. Maramraju D. Tomasi, et al. 035 R.A. Isoardi Argentina PET in Argentina: A Pioneer Project in Latin America (16:55) E.R. Noya S. Baigorria S.L. Mosconi 036 P. Pasawang Thailand Performance Evaluation of a Biograph 16 Hi-Rez PET/CT (17:10) T. Sontrapornpol Scanner at King Chulalongkorn Memorial Hospital C. Navikacheevin A. Krisanachinda 037 H.R. Ham Belgium F18-FDG-PET Reconstruction: Slice Thickness for Optimal (17:25) J. Keppens Resolution A. Dobbeleir I. Goethals 19 TUESDAY, 13 NOVEMBER 2007 08:00–09:00 CME – Image Interpretation Neurology & Cardiology Chair: M. Dondi, IAEA No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 005CME A. Cuocolo Italy Single-photon emission computer tomogrphy (SPECT) and (08:00) positron emission tomography (PET) imaging in Cardiology (invited) 006CME S. Minoshima USA Image Interpretation Neurology (SPECT and some PET) (08:30) (invited) 09:00–10:30 PET Neurology Chair: TBD Co-Chair: S. Minoshima, USA No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 18 038 K.J. Langen Germany Brain Tumor Diagnostics using F-labelled Amino Acids and (09:00) F.W. Floeth PET (invited) D. Pauleit G. Stoffels K. Hamacher, et al. 039 S. Minoshima USA Use PET in Epilepsy (invited) (09:20) 040 TBD PET Neurodegeneration (Parkinson's and Alzheimer's) (invited) (09:40) 041 M. Diksic Canada -[11C]Methyl-L-Tryptophan as Tracer for Identification of (10:00) Epileptic Foci Using Positron Emission Tomography Imaging 042 S. Tepmongkol Thailand How FDG-PET helps making Decision for Surgery in various (10:15) C. Locharernkul Difficult Subgroup of Temporal Lobe Epilepsy? K. Kingpet S. Sirisalipoch T. Chaiwatanarat 10:30–11:00 Coffee/Tea Break 20 TUESDAY, 13 NOVEMBER 2007 (cont’d) 11:00–12:30 PET Cardiology Chair: N. Tamaki, Japan Co-Chair: TBD No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 043 N. Tamaki Japan Cardiac Perfusion Imaging (invited) (11:00) 044 H.R. Schelbert USA Cardiac Metabolic Imaging (invited) (11:20) 045 M. Schwaiger Germany Imaging Peripheral Vascular Disease (invited) (11:40) 046 B.P. Tiwari India Myocardial Uptake of 18F-FDG in Whole body PET Studies (12:00) P. Kand N. Nair 82 047 K. Knešaurek AAPM Determination of Regional Myocardial Blood Flow by Rb PET (12:15) O.D. Almeida Imaging J. Machac Z. Zhang 12:30–14:00 Lunch Break 14:00–15:30 SPECT in the PET era Chair: J.-K. Chung, Korea, Rep.of Co-Chair: K.J. Langen, Germany No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 048 TBD SPECT Neurology (invited) (14:00) 049 A. Kjaer Denmark SPECT Oncology Imaging (invited) (14:20) 050 N. Tamaki Japan SPECT Metabolic Imaging (invited) (14:40) 051 P. Orellana Chile Screening of Asymptomatic Patients with Type 2 Diabetes (15:00) A. Baeza Mellitus for Silent Coronary Artery Disease with Stress V. Assef Myocardial Perfusion Imaging J.C. Quintana P. Olmos, et al. 052 J. Fettich Slovenia The Value of 99m-Tc Octreotide SPECT to localize (15:15) M. Hodolic Neuroendocrine Tumours for Successful Surgical Treatment S. Repse P. Peitl 15:30–16:00 Coffee/Tea Break 21 TUESDAY, 13 NOVEMBER 2007 (cont’d) - 16:00--17:30 Presentations and Panel Discussion: Training & Education Chair: A. Ellmann, South Africa (TBC) Co-Chair: H.H. Coenen, Germany (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 053 A. Bischof Delaloye Switzerland Issues on Training of Physicians/Technologists (invited) (16:00) 054 S. Schwarz USA Issues on Training of Radiochemists/Radiopharmacists (invited) (16:15) 055 G. El Fakhri USA Issues on Training of Medical Physicists (invited) (16:30) 056 H.E. Patterson Australia Meeting Training Needs in PET/CT; Extending DAT for the 21st (16:45) N. Watanabe IAEA Century M. Dondi IAEA B.F. Hutton UK (17:00) Discussions 22 WEDNESDAY, 14 NOVEMBER 2007 08:00–09:00 CME – Therapy Assessment and Planning Chair: F. Mut, Uruguay (TBC) No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 007CME H.A. Macapinlac USA Therapy Assessment & Planning in Lung Cancer (invited) (08:00) 008 CME D. Townsend USA Essentials for PET/CT Computation and QA for Treatment (08:30) Planning/Follow-Up (invited) 09:00–10:30 PET: Therapy Prediction/Assessment Chair: H.A. Macapinlac, USA Co-Chair: A.A. Lammertsma, Netherlands No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 057 E. Bombardieri Italy Radiotherapy Planning (invited) (09:00) 058 R. Baum Germany Role of PET and PET/CT in the Assessment of Response to (09:20) V. Prasad Chemotherapy (invited) 063 J.-N. Talbot France Prostate Cancer – Assessment and Therapy Follow-up (invited) (09:40) 059 A. Dimitrakopoulou- Germany Therapy Monitoring based on FDG-PET follow-up Studies for the (10:00) Strauss Prediction of Individual Survival M. Hoffmann M. Uppenkamp J. Rudi M. Eisenhut, et al. 060 P.S. Choudhury India Importance of SPECT Imaging in the Assessment of Tumor (10:15) E. Savio Uruguay Viability: Evaluation of an Indigenous Preparation of 99mTc- K.K. Solanki IAEA Glucarate A. Gupta India D. Doval, et al. 10:30–11:00 Coffee/Tea Break 23 WEDNESDAY, 14 NOVEMBER 2007 (cont’d) 11:00–12:30 Closing Session Chairs: M. Dondi, M. Haji-Saeid, K.K. Solanki, IAEA Host Government Representative, Thailand No. of Paper Designating Member Name Title IAEA-CN-157/ State/Organization 061 P. Conti USA Highlights (invited) (11:00) 062 M. Schwaiger Germany Future Directions - For Clinical PET and Molecular Nuclear (11:30) Medicine (invited) (12:00) M. Dondi IAEA Closing Remarks M. Haji-Saeid K. K. Solanki HG Representative Thailand 12:30 Closing 24 PARTICIPATION IN THE IAEA SCIENTIFIC MEETINGS Governments of Member States and those organizations whose activities are relevant to the meeting subject matter are invited to designate participants in the IAEA scientific conferences and symposia. In addition, the IAEA itself may invite a limited number of scientists as invited speakers. Only participants designated or invited in this way are entitled to present papers and take part in the discussions. Representatives of the press, radio, television or other information media and members of the public, the latter as “observers”, may also be authorized to attend, but without the right to take part in the proceedings. Scientists interested in participating in any of the IAEA meetings should request information from the Government authorities of their own countries, in most cases the Ministry of Foreign Affairs or national atomic energy authority. PUBLICATIONS Proceedings The proceedings of the symposium containing selected presentations and posters delivered at the meeting, as well as summaries, will be published by the IAEA as soon as possible after the symposium. Orders All IAEA publications may be ordered at the Information Desk or directly from the Sales and Promotion Unit, International Atomic Energy Agency, P.O. Box 100, A-1400 Vienna, Austria. Fax: (+43 1) 2600-29302 Email: email@example.com Internet: http://www.iaea.org/books 25